Company / Operating Income
MBX Biosciences, Inc. Operating Income History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$68.2M
FY2024
5-year range
-$68.2M / -$35.3M
FY2023-FY2024
Trend
-93.1%
vs FY2023
Sector context
#78 of 204
Health Care
What the data says
At -$68M, MBX Biosciences, Inc.'s operating income ranks #78 of 204 in the Health Care sector.
Based on SEC 10-K filings.
-$68M in FY2024.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#78 of 204 in Health CareTop 38% of 204This company -$68.2M Sector average $107.7M
▼
-163.3% below sector average
Key checks
Key Insights
- In FY2024, operating income decreased 93.1% year-over-year.
- Ranks #78 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 9.64 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$68.2M | -93.1% |
| FY2023 | -$35.3M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026